
taurx therapeutics ltd
TauRx Therapeutics Initiates Two Phase III Trials For Alzheimer’s Drug
Singapore-based biotech company TauRx Therapeutics Ltd announced today the initiation of two global Phase III clinical trials for its Alzheimer’s disease drug.
